This phase of testing is a big deal for any major drug, as it typically involves larger studies with more patients, which means lots of new data
In addition to these advanced treatments, your journey includes a custom dietary and lifestyle plan designed by Noelle Brown Diamond, RD
Patients with obesity-related complications frequently have stronger medical necessity documentation because weight loss may improve overall health outcomes
Until retatrutide receives a positive marketing authorisation from the MHRA, it cannot be legally sold, supplied, or prescribed as a standard treatment in the UK
doi: 10.1055/s-0028-1082326 54 PuglisiSRossiniAPoliRDugheraFPiaATerzoloMet al
"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026
